Clinical Trial Update: A Clinical Study to Investigate the Effect of a Partially Hydrolysed Infant Formula With Added Synbiotics on the Development of Allergic Manifestations in Infants at High Risk of Developing Allergy [Phase 3]

View source ↗

Summary

Phase 3 clinical trial investigating partially hydrolysed infant formula with added synbiotics for preventing allergic manifestations in high-risk infants has b…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Immunity

Drugs mentioned

• Partially hydrolysed infant formula with added synbiotics

Snippet

Sponsor: Nutricia Research | Conditions: Immunity | Phase 3 | Status: WITHDRAWN